AMED Amedisys Inc

Price (delayed)

$298.10

Market cap

$9.78B

P/E Ratio

58.34

Dividend/share

N/A

EPS

$5.11

Enterprise value

$10.07B

Sector: Healthcare
Industry: Medical Care Facilities

Highlights

The net income has increased by 31% YoY and by 30% QoQ
AMED's EPS is up by 29% YoY and by 29% from the previous quarter
The company's debt rose by 25% YoY but it fell by 18% QoQ
The P/E is 38% above the 5-year quarterly average of 42.4 and 26% above the last 4 quarters average of 46.3
The quick ratio has decreased by 13% QoQ and by 4.5% YoY

Key stats

What are the main financial stats of AMED
Market
Shares outstanding
32.81M
Market cap
$9.78B
Enterprise value
$10.07B
Valuations
Price to earnings (P/E)
58.34
Price to book (P/B)
12.8
Price to sales (P/S)
4.82
EV/EBIT
50.75
EV/EBITDA
38.38
EV/Sales
4.98
Earnings
Revenue
$2.02B
EBIT
$198.42M
EBITDA
$262.4M
Free cash flow
$293.8M
Per share
EPS
$5.11
Free cash flow per share
$9
Book value per share
$23.29
Revenue per share
$61.89
TBVPS
$17.97
Balance sheet
Total assets
$1.6B
Total liabilities
$844.98M
Debt
$404.27M
Equity
$756.21M
Working capital
-$26.25M
Liquidity
Debt to equity
0.53
Current ratio
0.94
Quick ratio
0.84
Net debt/EBITDA
1.1
Margins
EBITDA margin
13%
Gross margin
41.9%
Net margin
8.2%
Operating margin
9.8%
Efficiency
Return on assets
11.2%
Return on equity
23.8%
Return on invested capital
39.5%
Return on capital employed
17%
Return on sales
9.8%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

AMED stock price

How has the Amedisys stock price performed over time
Intraday
1.43%
1 week
0.77%
1 month
2.86%
1 year
65.33%
YTD
1.63%
QTD
1.63%

Financial performance

How have Amedisys's revenue and profit performed over time
Revenue
$2.02B
Gross profit
$847.26M
Operating income
$198.67M
Net income
$166.11M
Gross margin
41.9%
Net margin
8.2%
The net income has increased by 31% YoY and by 30% QoQ
The company's net margin rose by 26% QoQ and by 22% YoY
AMED's operating income is up by 15% year-on-year and by 9% since the previous quarter
AMED's gross profit is up by 10% year-on-year and by 5% since the previous quarter

Growth

What is Amedisys's growth rate over time

Valuation

What is Amedisys stock price valuation
P/E
58.34
P/B
12.8
P/S
4.82
EV/EBIT
50.75
EV/EBITDA
38.38
EV/Sales
4.98
The P/E is 38% above the 5-year quarterly average of 42.4 and 26% above the last 4 quarters average of 46.3
AMED's EPS is up by 29% YoY and by 29% from the previous quarter
The P/B is 113% more than the 5-year quarterly average of 6.0 and 41% more than the last 4 quarters average of 9.1
AMED's equity is up by 25% year-on-year and by 4.9% since the previous quarter
The P/S is 154% more than the 5-year quarterly average of 1.9 and 51% more than the last 4 quarters average of 3.2
Amedisys's revenue has increased by 7% YoY and by 2.5% from the previous quarter

Efficiency

How efficient is Amedisys business performance
The ROE has grown by 23% from the previous quarter
The ROA is up by 22% since the previous quarter but it has declined by 4.3% year-on-year
The ROIC has grown by 11% from the previous quarter but it has contracted by 9% YoY
AMED's ROS is up by 7% from the previous quarter and by 3.2% YoY

Dividends

What is AMED's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for AMED.

Financial health

How did Amedisys financials performed over time
AMED's total assets is 90% higher than its total liabilities
The company's total liabilities rose by 39% YoY but it fell by 8% QoQ
AMED's total assets is up by 32% YoY but it is down by 2.6% QoQ
The company's debt is 47% lower than its equity
AMED's equity is up by 25% year-on-year and by 4.9% since the previous quarter
The company's debt rose by 25% YoY but it fell by 18% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.